5X6-31304-55640
2 vaccinations
2 coded responses
24 check-ins
1 free-text entry
0 call cases
- Sex
- Male
- Age at first dose
- 0-4
- ZIP prefix
- 752 / TX
- Registered
- 2022-06-22
- Relationship
- Child or adolescent in my care
- Guardian
- 27M-24350-03160
- Race
- White
- Ethnicity
- Hispanic or Latino
Timeline
-
2022-06-22
Registered in v-safe
-
2022-06-22
Dose 1 — Moderna
- 2022-06-22
- 2022-06-23
- 2022-06-24
- 2022-06-25
- 2022-06-26
- 2022-06-28
- 2022-06-29
- 2022-07-06
- 2022-07-13
- 2022-07-20
-
2022-07-22
Dose 2 — Moderna
- 2022-07-22
- 2022-07-23
- 2022-07-24
- 2022-07-26
- 2022-07-27
- 2022-07-28
- 2022-07-29
- 2022-08-05
- 2022-08-12
- 2022-08-19
-
2022-08-26
Survey response — day 35, dose 2, under 3MedDRA: COVID-19 — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: CovidMedDRA releases: 2024-11 · check-in free text available
- 2022-09-02
- 2022-10-23
-
2023-01-20
Survey response — 6 months, dose 2, under 3MedDRA: Gastrointestinal viral infection, Nasopharyngitis — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activitiesMedDRA releases: 2024-11
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2022-06-22 | Moderna | No |
| 2 | 2022-07-22 | Moderna | No |
Free text
Release 12 (Under 3) — day 35, dose 2, under 3
Symptoms: Covid
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | COVID-19 | · | · | ✓ |
| SD | Gastrointestinal viral infection | · | · | ✓ |
| SD | Nasopharyngitis | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release